Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Industrial Institute of Antibiotics (SIIA) is a prominent Chinese research organization dedicated to the field of microbial medicine and antibiotic industrialization. Established in 1965 and currently operating as a subsidiary of Sinopharm, SIIA specializes in the research, development, and pilot-scale production of anti-infective drugs, including penicillins, cephalosporins, and macrolides. The institute maintains a comprehensive platform for microbial strain breeding, fermentation engineering, and chemical synthesis. SIIA serves as a critical R&D hub for the China National Pharmaceutical Group, driving innovation in drug delivery systems and the development of high-value generic and novel therapeutic agents. Its facilities include the National Engineering Research Center for Antibiotics, which supports the translation of laboratory discoveries into industrial-scale manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Industrial Institute of Antibiotics.